Any stock, in context
ASTRAZEN · Healthcare
AstraZeneca Pharma India Limited
Observation · 15 Oct 2026
How these are readAstraZeneca Pharma India closed at ₹5,937.0 on 15 Oct 2026, 26.2% below its 200-day average and 14.3% below its 50-day average: below both lines. It sits 39.3% below its highest close of the past year, in the bottom fifth of its one-year range. Over three months it fell 25.7%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- −26.2%
- the long line
- vs 50-day
- −14.3%
- the short line
- From 52w high
- −39.3%
- ₹5,640.0₹9,849.5
- 3 months
- −25.7%
- sector median −2.7% · 143 of 146
Listed outside the Nifty indices · Healthcare (sector mapped from its industry) · EQ series · median traded value ₹4.32 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- −0.23%
- 1W
- –
- 1M
- −11.33%
- 3M
- −25.67%
- YTD
- –
- 1Y
- −34.81%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.